5d
News Medical on MSNDiabetes medications may help lower COPD flare-up risk, study findsThe study reveals SGLT-2is are linked to fewer COPD exacerbations in type 2 diabetes, suggesting a need for further clinical ...
People with type 2 diabetes who take GLP-1 and SGLT-2 medications have a lower risk of having COPD symptom flare-ups than ...
Sodium-glucose cotransporter 2, or SGLT2, inhibitors and glucagon-like peptide-1 receptor agonists lowered the risk for COPD ...
People in rural areas are at greater risk of developing chronic obstructive pulmonary disease (COPD) due to a variety of factors. We explain why.
Lyn Iemma, aged 75 years at the time of writing, would not describe her life as dramatic. Born and raised in Perth, WA, Australia, this thriving but relaxed city is the place she has always called ...
Recent findings suggest that post-COVID chronic cough may be driven by neurological factors, not just respiratory issues.
RAs, and DPP-4is may offer benefits for patients with COPD, but clinical evidence comparing their effectiveness in reducing ...
Researchers have found in a phase 3 trials that Dupilumab significantly reduced moderate or severe COPD exacerbations ...
Pharm Exec’s 20th Annual Pipeline Report examines the emerging drug development trends and surging investments in five ...
The vulnerable groups and their silent struggles While heart attack risk increases for everyone in the cold weather, certain groups are far m ...
Pulmonx (NASDAQ:LUNG – Get Free Report) is anticipated to issue its quarterly earnings data after the market closes on Wednesday, February 19th. Analysts expect the company to announce earnings of ($0 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results